Regulatory alignment and mutual recognition for the manufacture of medicines, needs of the pharmaceutical industry in the face of ‘Brexit’

Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy organize a new seminar focused on preparations for the end of the transitional period Source: www.farmaindustria.es On December 31, the transitional period marked by the European and British authorities […]

Takeda launches a website that groups all its clinical trials

So, in an exercise of transparency, anyone can have access to this data Carmen Montoto, Takeda Medical Director in Spain Source: www.redaccionmedica.com As part of its commitment to research, aimed at improving the quality of life of patients, Takeda has launched a website that groups all its clinical trials, including those of Shire, a company […]

Farmaindustria bets on digitization to consolidate Spain in drug trials

In the workshop “Digital challenges in the management of clinical trials”, organized by Farmaindustria, its attendees have shown their commitment to digitization to help Spain consolidate its international position in clinical drug research. Spain is an international reference for conducting clinical trials of new drugs, as shown in the research effort deployed to deal with […]

BMS celebrates the first international forum aimed at the research community of Spain and Portugal

The objective of this meeting has been to present the latest advances in the area of Oncology with experts of national and international origin and to address the main challenges in cancer management. The pharmaceutical company Bristol Myers Squibb (BMS) has held the first edition of “Leading the Science”, a virtual symposium where national and […]

Research in breast cancer: more survival and better quality of life

Nine out of ten women diagnosed in Spain survive to 5 years The development of more precise, effective treatments with fewer side effects, together with the increase in early detection, has made possible a shift in the prognosis of the disease This Monday, October 19, is celebrated the International Day of Breast Cancer Source: www.farmaindustria.es […]

Covid-19 has delayed cancer clinical trial programs

  Source: www.redaccionmedica.com María Blasco recalls that investment in science “is not even at the levels prior to 2010” Scientists gathered at the meeting ‘A new era for cancer research: towards the involvement of the whole society’, organized by the National Center for Cancer Research (CNIO), have asked to increase resources for cancer research and […]

Immunotherapy before surgery doubles survival in lung cancer

A Spanish study “opens a door in a global therapeutic approach” that would allow more patients to be cured Source: www.redaccionmedica.com The survival prospects of patients with lung cancer in intermediate stages (which can be operated on, but in which the tumor has already spread to surrounding lymph nodes) have been turned upside down thanks […]

The fight against cancer is not stopped by the coronavirus: four out of ten new investigational drugs are antitumor

Even in the harshest months of the pandemic, pharmaceutical companies have continued to promote studies to admit patients, when it was the only therapeutic alternative for them Average survival five years after diagnosis continues to increase in Spain and is expected to continue to do so thanks to the significant therapeutic advances in recent years. […]

Comprehensive commitment of the pharmaceutical industry to patient safety

Clinical trials, pharmacovigilance and verification are just some of the fields of action where pharmaceutical companies actively work to guarantee the well-being of people in their relationship with medicines. Source: www.consalud.es The increased complexity in healthcare and the constant and improved evolution of personalized treatments have made it necessary for all the agents that make […]

Arranca el primer ensayo en humanos de una vacuna Covid-19 en España

Janssen’s coronavirus vaccine will be tested in 190 Spanish volunteers and the study will last between 4 and 6 months Source: www.redaccionmedica.com Spain begins, this week, the first clinical trial for the covid vaccine in phase 2, in humans, which is being developed by the pharmaceutical company Janssen in the Madrid hospitals of La Paz […]